Our services
CMC Regulatory Consulting
Chemistry, Manufacturing & Controls strategy that stands up to agency scrutiny
Minerva Regulatory Consulting helps pharmaceutical and biotechnology companies build, defend and maintain the CMC sections of their regulatory submissions — from early development through marketing authorisation and lifecycle management.
Biologics & Small Molecule Regulatory Consulting
Minerva supports biologics and small molecule programmes alike — from monoclonal antibodies and recombinant proteins to orally administered dose forms. We cover characterisation, impurity control, comparability and biosimilar development across the full product lifecycle.
ATMP Regulatory Consulting
Specialist regulatory support for cell and gene therapies and other ATMPs
Advanced therapy medicinal products face a distinct regulatory framework, from ATMP classification to the specific quality and clinical data agencies expect. Minerva guides cell and gene therapy developers through every stage.
